Original Research

Muscular Involvement in Dengue Fever: Clinical Spectrum and Pathophysiological Mechanisms

DOI https://doi.org/10.70302/jpsim.v7i3.2648
Received: 23 Feb 2026 Revised: 03 Jun 2026 Accepted: 12 Aug 2026 Published Online: 21 Aug 2026

Abstract

Objectives

To determine the prevalence and clinical characteristics of muscular involvement in dengue infection, including myalgia, myositis, rhabdomyolysis, and hypokalaemic paralysis, by evaluating clinical presentations and laboratory parameters—particularly creatine phosphokinase (CPK) levels—in patients presenting to the outpatient department and those admitted to the dengue ward.

Methods

We conducted a prospective descriptive study including 75 patients with confirmed dengue fever. Demographic, clinical, and biochemical data were collected. Muscular involvement was classified as myalgia, myositis, rhabdomyolysis, or hypokalemic paralysis. Creatine phosphokinase (CPK) levels and other laboratory parameters were recorded. Associations were assessed using chi-square/Fisher’s exact tests, Mann–Whitney U test, and odds ratios with 95% confidence intervals.

Results

The mean age of participants was 36.8 ± 16.5 years; 70.7% were male. Elevated CPK was observed in 48.0% of patients. Rhabdomyolysis occurred exclusively in those with elevated CPK (22.2% vs. 0.0%; Fisher’s exact p = 0.0018; OR = 22.3, 95% CI 1.23–404.2). Muscle weakness was significantly more common in patients with elevated CPK (44.4% vs. 5.1%; χ² = 13.78, p < 0.001; OR = 14.8, 95% CI 3.09–70.95). No significant association was found between CPK status and self-reported muscle pain (p = 0.968). No participants exhibited electrolyte imbalance.

Conclusion

Muscular complications, including rhabdomyolysis and weakness, are significantly associated with elevated CPK in dengue fever. Routine CPK monitoring may help in early detection of severe muscular involvement. Larger, multicenter studies are warranted.

Keywords
Dengue fever Myositis Rhabdomyolysis Creatinine Phosphokinase.

How to Cite This Article

Munir A, Zeb S, Majid A, Hafsa H. Muscular Involvement in Dengue Fever: Clinical Spectrum and Pathophysiological Mechanisms. J Pak Soc Intern Med. 2026;7(3):257–261. doi:10.70302/jpsim.v7i3.2648

⭳ Download PDF

Conflict of Interest

The authors declare no conflict of interest.

Disclosed in accordance with ICMJE and COPE guidelines.

Funding

This research received no specific grant from any funding agency.

Funder information follows the Crossref Funder Registry standard.

Ethics Statement

not_applicable

Conducted in accordance with the Declaration of Helsinki.

References

  1. Garg RK, Malhotra HS, Jain A, Malhotra KP. Dengue-associated neuromuscular complications. Neurology India. 2015;63(4).
  2. Brady OJ, Gething PW, Bhatt S, Messina JP, Brownstein JS, Hoen AG, et al. Refining the global spatial limits of dengue virus transmission by evidence-based consensus. PLoS Negl Trop Dis. 2012;6(8):e1760.
  3. Organization WH. Dengue - Pakistan [Internet]. 2022 [cited 2025 May 25]. Available from: https://www.who.int/emergencies/disease-outbreak-news/item/2022-DON414.
  4. Guard RW, Stallman ND, Wiemers MA. Dengue in the northern region of Queensland, 1981-1982. Med J Aust. 1984;140(13):765–9.
  5. Halsey ES, Marks MA, Gotuzzo E, Fiestas V, Suarez L, Vargas J, et al. Correlation of serotype-specific dengue virus infection with clinical manifestations. PLoS Negl Trop Dis. 2012;6(5):e1638.
  6. Mohammed HP, Ramos MM, Rivera A, Johansson M, Muñoz-Jordan JL, Sun W, et al. Travel-associated dengue infections in the United States, 1996 to 2005. J Travel Med. 2010;17(1):8–14.
  7. Dalugama C, Ralapanawa U, Jayalath T. Dengue Myositis and Review of Literature. 2017;2:16–8.
  8. Sadiqa A, Hayyan U, Waqar Z, Pasha T. Myositis as a complication of dengue viral infection. Pakistan Journal of Neurological Sciences. 2023;18(01).
  9. Putri A, Arunsodsai W, Hattasingh W, Sirinam S. DENV-1 infection with rhabdomyolysis in an adolescent: A case report and review of challenge in early diagnosis and treatment. Heliyon. 2024;10(17):e36379.
  10. Gulia M, Dalal P, Gupta M, Kaur D. Concurrent Guillain-Barré syndrome and myositis complicating dengue fever. BMJ Case Rep. 2020;13(2).
  11. Garg RK, Malhotra HS, Jain A, Malhotra KP. Dengue-associated neuromuscular complications. Neurol India. 2015;63(4):497–516.
  12. Malhotra HS, Garg RK. Dengue-associated hypokalemic paralysis: causal or incidental? J Neurol Sci. 2014;340(1-2):19–25.
  13. Kulkarni MJ, Sarathi V, Bhalla V, Shivpuri D, Acharya U. Clinico-epidemiological profile of children hospitalized with dengue. Indian J Pediatr. 2010;77(10):1103–7.
  14. Rajajee S, Ezhilarasi S, Rajarajan K. Benign acute childhood myositis. Indian J Pediatr. 2005;72(5):399–400.
  15. Paliwal VK, Garg RK, Juyal R, Husain N, Verma R, Sharma PK, et al. Acute dengue virus myositis: a report of seven patients of varying clinical severity including two cases with severe fulminant myositis. J Neurol Sci. 2011;300(1-2):14–8.
  16. Sangle SA, Dasgupta A, Ratnalikar SD, Kulkarni RV. Dengue myositis and myocarditis. Neurol India. 2010;58(4):598–9.
  17. Sargeant T, Harris T, Wilks R, Barned S, Galloway-Blake K, Ferguson T. Rhabdomyolysis and dengue Fever: a case report and literature review. Case Rep Med. 2013;2013:101058.
  18. Acharya S, Shukla S, Mahajan SN, Diwan SK. Acute dengue myositis with rhabdomyolysis and acute renal failure. Ann Indian Acad Neurol. 2010;13(3):221–2.
  19. Hira HS, Kaur A, Shukla A. Acute neuromuscular weakness associated with dengue infection. J Neurosci Rural Pract. 2012;3(1):36–9.
  20. Kayal AK, Goswami M, Das M, Jain R. Clinical and biochemical spectrum of hypokalemic paralysis in North: East India. Ann Indian Acad Neurol. 2013;16(2):211–7.

Reference list indexed for Google Scholar and ResearchGate. DOI links resolve via doi.org.

CC BY CC BY 4.0 This article is published under the Creative Commons Attribution 4.0 International License. May be shared and adapted with attribution. © 2026 Journal of Pakistan Society of Internal Medicine.